HCPCS Level IIdrugActive
J9298
Inj nivol relatlimab 3mg/1mg
BETOS: O1D
Effective: 2022-10-01
Description
Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Opdualag
Manufacturer
E.R. Squibb & Sons, L.L.C.
HCPCS Dosage
3 MG - 1 MG
Billing Units
80.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.